Clinical Trial Update: Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating isolated limb perfusion of melphalan with or without tumor necrosis factor for soft tissue sarcoma of the arm or leg; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Melphalan (Melphalan)
• Tumor necrosis factor (tumor necrosis factor)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Stage IVB Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED